Geneva, March 20 -- International Clinical Trials Registry received information related to the study (KCT0011645) titled 'ED95 of remimazolam for loss of consciousness when used with remifentanil in the elderly' on Feb. 24.
Study Type: Interventional Study
Study Design:
Primary Purpose : Treatment, Intervention Model : Parallel, Blinding/Masking : Double, Blinding Target : Subject, Investigator, Allocation : RCT
Primary Sponsor: Ajou University Hospital
Condition:
Not Applicable
Intervention:
Drug : Subjects are allocated to either the Control group (Normal Saline) or the Remifentanil group (Remifentanil effect-site concentration 2.0 ng/ml). Remimazolam is then administered for anesthesia induction. The dose of remimazolam is det...